← Eichor
Condition: Erythropoietin Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Erythropoietin

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

EVR and EPO for Liver Transplant Tolerance
Phase 1 · 3 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06832189
Pegmolesatide Treatment for Anemia in Patients Undergoing Long-term Dialysis
Phase 4 · 1 location(s) · Chinese PLA General Hospital · NCT07045155
The Effect of Salicylate on Platelet Function in CKD (Chronic Kidney Disease) Patients Treated With Aranesp
NA · 1 location(s) · Zealand University Hospital · NCT04330729
The Effect of Erythropoietin on Alveolar Fluid Clearance in Patients With Acute Respiratory Distress Syndrome
NA · 1 location(s) · Second Affiliated Hospital of Wenzhou Medical University · NCT05857891
Study Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being Ineligible to ESA
Phase 1/Phase 2 · 40 location(s) · Groupe Francophone des Myelodysplasies · NCT05181735
ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients
Phase 3 · 41 location(s) · Australian and New Zealand Intensive Care Research Centre · NCT04588311
PK, PD, Safety and Immunogenicity Study of Erythropoietin of Incepta Pharmaceuticals Ltd With Eprex (Janssen-Cilag).
Phase 3 · 1 location(s) · Incepta Pharmaceuticals Ltd · NCT07025681
Erythropoietin - Albumin Platelet-rich Fibrin in Transcrestal Sinus Lifting With Simultaneous Implant Placement
NA · 1 location(s) · Alexandria University · NCT07150858
Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Dise
Phase 3 · 2 location(s) · Biocad · NCT07119372
Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial)
Phase 3 · 10 location(s) · Imperial College London · NCT05395195
Use of Epoetin Alfa and Iron Derisomaltose in Treatment of Anemia in Patients With Sepsis or Septic Shock: a Randomized
Phase 4 · 1 location(s) · Piotr Czempik · NCT06670963
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myel
Phase 3 · 156 location(s) · Takeda · NCT07422480
The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion
NA · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT06012760
Safety of Erythropoietin and Melatonin for Very Preterm Infants With Intraventricular Hemorrhage
Phase 1 · 2 location(s) · Johns Hopkins University · NCT05617833
Evaluation of Erythropoietin on Alveolar Ridge Preservation
Phase 4 · 1 location(s) · Ain Shams University · NCT06513039
Evaluation of Response to Biosimilar Erythropoietin Alfa Therapy in Anemic Patients With Myelodysplastic Syndrome
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06764511
Erythropoietin Gel Effect on Dental Implant Stability
NA · 1 location(s) · Al-Azhar University · NCT06665451
Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic
Phase N/A · 1 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT05931718
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.